Lipella Pharmaceuticals I... (LIPO)

NASDAQ: LIPO · Real-Time Price · USD

2.50

-0.13 (-5.12%)

At close: Apr 29, 2025, 3:59 PM

2.45

-2.00%

After-hours: Apr 29, 2025, 04:00 PM EDT

Lipella Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Mar 31, 2021
Cash & Equivalents	2.18M	1.35M	1.19M	2.11M	3.29M	2.41M	3.11M	4.02M	5.12M	114.77K	434.98K	414.4K	1.41M	-606.74K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	600.54K	300.55K	1.21M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-1	n/a	-122.55K	n/a	-150.82K	-164.63K	-178.23K	n/a	n/a	-606.74K
Receivables	84.71K	31.08K	35.33K	68.93K	32.29K	53.14K	28.04K	83.97K	113.66K	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	-31.08K	n/a	n/a	n/a	-261.01M	-253.12M	n/a	-113.66K	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	31.08K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	2.62M	2.08M	2.08M	3.01M	3.43M	2.67M	3.37M	4.48M	5.8M	709.15K	872.53K	1.33M	1.81M	606.74K
Property-Plant & Equipment	56.62K	80.14K	103.28K	126.07K	147.89K	169.88K	122.55K	136.79K	150.82K	164.63K	178.23K	187.22K	204.8K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	56.62K	80.14K	103.28K	126.07K	147.89K	169.88K	122.55K	136.79K	150.82K	164.63K	178.23K	187.22K	204.8K	-606.74K
Total Assets	2.67M	2.16M	2.18M	3.14M	3.58M	2.84M	3.49M	4.61M	5.95M	873.78K	1.05M	1.52M	2.01M	n/a
Account Payables	388.19K	459.45K	178.36K	293.83K	138.02K	303.05K	22.06K	148.92K	384.36K	352.36K	55.48K	56.46K	46.9K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-158.25M	-215.74M	n/a	n/a	n/a	n/a	n/a	178.97K	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	250K	275K	25K	25K	25K	25K	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-357.93K	n/a
Total Current Liabilities	754.42K	701.19K	480.31K	551.88K	385.36K	548.73K	298.8K	717.45K	1.18M	741.65K	447.69K	346.31K	340.63K	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50K	50K	50K	50K	n/a
Other Long-Term Liabilities	n/a	1.00	1.00	n/a	n/a	n/a	n/a	n/a	n/a	33.62K	32.52K	31.43K	30.35K	n/a
Total Long-Term Liabilities	n/a	1.00	1.00	24K	47.37K	70.48K	65.39K	80.94K	96.26K	194.96K	250.88K	249.79K	248.71K	n/a
Total Liabilities	754.42K	701.19K	480.31K	575.88K	432.73K	619.21K	364.19K	798.39K	1.27M	936.61K	698.57K	596.1K	589.34K	n/a
Total Debt	47.6K	70.83K	93.68K	115.7K	136.59K	157.76K	126.18K	390.46K	429.52K	243.36K	256.99K	265.78K	282.96K	n/a
Common Stock	121.00	109.00	761.00	704.00	605.00	580.00	574.00	574.00	574.00	1.05K	967.00	967.00	967.00	n/a
Retained Earnings	-15.34M	-13.9M	-12.45M	-11.52M	-10.32M	-9.63M	-8.31M	-6.77M	-5.7M	-5.34M	-4.63M	-3.85M	-3.11M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	0.00	n/a	-3.85M	-3.11M	463.16K
Shareholders Equity	1.92M	1.46M	1.7M	2.56M	3.14M	2.22M	3.13M	3.82M	4.68M	-62.82K	352.19K	920.75K	1.42M	463.32K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	600.54K	300.55K	1.21M